Epstein-Barr Virus Antigens of Therapeutic Importance: Presentation via HLA Class I and Class II Pathways

Project Details

Short titleEpstein-Barr Virus Antigens of Therapeutic Importance: Presentation via HLA Class I and Class II Pathways
StatusFinished
Effective start/end date1/01/0331/12/05

Funding

  • Cancer Research UK